Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
RESEARCH TOOLSreports
Holding CHJTF?
Track your performance easily
CHJTF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.44 - $0.97
Previous Close$0.59
Volume1.26K
Average Volume (3M)64.13K
Market Cap
$7.96B
Enterprise Value$5.53B
Total Cash (Recent Filing)¥13.41B
Total Debt (Recent Filing)¥682.56M
Price to Earnings (P/E)8.6
Beta0.52
Next Earnings
Nov 19, 2024EPS Estimate
$0.02Next Dividend Ex-Date
Oct 31, 2024Dividend Yield6.45%
Share Statistics
EPS (TTM)0.07
Shares OutstandingN/A
10 Day Avg. Volume6,984
30 Day Avg. Volume64,130
Standard Deviation0.13
R-Squared0.00169
Alpha0.00336
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)2.85
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.90Price Target Upside45.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
CSPC Pharmaceutical Group News
PremiumCompany Announcements
CSPC Pharmaceutical’s New Hypertension Drug Trials Approved
PremiumCompany Announcements
CSPC Pharmaceutical Plans HK$5 Billion Share Buy-BackPremiumCompany Announcements
CSPC Pharmaceutical’s New Antifungal Drug Approved
PremiumCompany Announcements
CSPC Pharmaceutical’s New Chemotherapy Nausea Treatment Approved
PremiumCompany Announcements
CSPC Pharmaceutical Welcomes New R&D President
PremiumCompany Announcements
CSPC Pharmaceutical Expands Oncology Portfolio
PremiumCompany Announcements
CSPC Pharma Reports Steady Growth and Shareholder Rewards
PremiumCompany Announcements
CSPC Pharmaceutical Declares HKD 0.16 Interim DividendBulls Say, Bears Say
Bulls Say
Dividend YieldShare price correction has driven the dividend yield to approximately 6%, which should ease near-term selling pressure.
Growth DriversInvestors are expected to shift focus to new product sales ramp-up, projected to have a 52% compound annual growth rate (CAGR).
Profit MarginGross profit margin improved to 71.6% in the first half of the year due to a higher proportion of revenue from finished drugs.
Bears Say
Earnings2Q24 revenue and underlying profit were over 10% below market expectations, primarily due to weak oncology sales.
Financial PerformanceHigher R&D expense ratios are partly offsetting financial gains.
SalesSales targets for new products have been revised downward as a result of delays in hospital listings.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
3.78% Mutual Funds
6.42% Other Institutional Investors
89.80% Public Companies and
Individual Investors
CHJTF FAQ
What was CSPC Pharmaceutical Group Limited’s price range in the past 12 months?
CSPC Pharmaceutical Group Limited lowest stock price was $0.44 and its highest was $0.97 in the past 12 months.
What is CSPC Pharmaceutical Group Limited’s market cap?
Currently, no data Available
When is CSPC Pharmaceutical Group Limited’s upcoming earnings report date?
CSPC Pharmaceutical Group Limited’s upcoming earnings report date is Nov 19, 2024 which is in 60 days.
How were CSPC Pharmaceutical Group Limited’s earnings last quarter?
CSPC Pharmaceutical Group Limited released its earnings results on Aug 21, 2024. The company reported $0.017 earnings per share for the quarter, missing the consensus estimate of $0.02 by -$0.003.
Is CSPC Pharmaceutical Group Limited overvalued?
According to Wall Street analysts CSPC Pharmaceutical Group Limited’s price is currently Undervalued.
Does CSPC Pharmaceutical Group Limited pay dividends?
CSPC Pharmaceutical Group Limited pays a Annually dividend of $0.02 which represents an annual dividend yield of 6.45%. See more information on CSPC Pharmaceutical Group Limited dividends here
What is CSPC Pharmaceutical Group Limited’s EPS estimate?
CSPC Pharmaceutical Group Limited’s EPS estimate is $0.02.
How many shares outstanding does CSPC Pharmaceutical Group Limited have?
CSPC Pharmaceutical Group Limited has 11,859,742,000 shares outstanding.
What happened to CSPC Pharmaceutical Group Limited’s price movement after its last earnings report?
CSPC Pharmaceutical Group Limited reported an EPS of $0.017 in its last earnings report, missing expectations of $0.02. Following the earnings report the stock price went down -10.39%.
Which hedge fund is a major shareholder of CSPC Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in CHJTF
---
CSPC Pharmaceutical Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.72%
12-Months-Change
Fundamentals
Return on Equity
17.87%
Trailing 12-Months
Asset Growth
9.64%
Trailing 12-Months
Company Description
CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.
---
CHJTF Stock 12 Month Forecast
Average Price Target
$0.90
▲(45.30% Upside)
Technical Analysis
Achieve Life Sciences
―
Amphastar Pharmaceuticals
―
ANI Pharmaceuticals
―
China Pharma Holdings
―
Best Analysts Covering CHJTF
1 Year
1 Year Success Rate
1/12 ratings generated profit
1 Year Average Return
-16.46%
reiterated a buy rating 30 days ago
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 8.33% of your transactions generating a profit, with an average return of -16.46% per trade.
---